This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2024 Jun;30(6):1788-1789.

doi: 10.1038/s41591-024-02890-2.

Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

Affiliations

Affiliations

¹ Mount Sinai Heart, Icahn School of Medicine, Mount Sinai Health System, New York City, NY, USA. dlbhattmd@post.harvard.edu.
² Louisville Metabolic and Atherosclerosis Research Center, University of Louisville School of Medicine, Louisville, KY, USA.
³ Corporal Michael J. Crescenz VA Medical Center and Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Family Medicine Clinic Science, Lampasas, TX, USA.
⁵ ZDROWIE Osteo-Medic, Bialystok, Poland.
⁶ Manassas Clinical Research Center, Manassas, VA, USA.
⁷ 89bio Inc., San Francisco, CA, USA.
⁸ Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

PMID: 38438737
PMCID: PMC11186769
DOI: 10.1038/s41591-024-02890-2

Published Erratum

Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

Deepak L Bhatt et al. Nat Med. 2024 Jun.

. 2024 Jun;30(6):1788-1789.

doi: 10.1038/s41591-024-02890-2.

Authors

Affiliations

¹ Mount Sinai Heart, Icahn School of Medicine, Mount Sinai Health System, New York City, NY, USA. dlbhattmd@post.harvard.edu.
² Louisville Metabolic and Atherosclerosis Research Center, University of Louisville School of Medicine, Louisville, KY, USA.
³ Corporal Michael J. Crescenz VA Medical Center and Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
⁴ Family Medicine Clinic Science, Lampasas, TX, USA.
⁵ ZDROWIE Osteo-Medic, Bialystok, Poland.
⁶ Manassas Clinical Research Center, Manassas, VA, USA.
⁷ 89bio Inc., San Francisco, CA, USA.
⁸ Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands.

PMID: 38438737
PMCID: PMC11186769
DOI: 10.1038/s41591-024-02890-2

No abstract available

PubMed Disclaimer

Figures

Fig. 1 — Fig. 1
Original and revised Fig. 3d.

See this image and copyright information in PMC

Erratum for

The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.
Bhatt DL, Bays HE, Miller M, Cain JE 3rd, Wasilewska K, Andrawis NS, Parli T, Feng S, Sterling L, Tseng L, Hartsfield CL, Agollah GD, Mansbach H, Kastelein JJP; ENTRIGUE Principal Investigators. Bhatt DL, et al. Nat Med. 2023 Jul;29(7):1782-1792. doi: 10.1038/s41591-023-02427-z. Epub 2023 Jun 24. Nat Med. 2023. PMID: 37355760 Free PMC article. Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources